Pneumocystis Pneumonia During Combined Therapy of Infliximab, Corticosteroid, and Azathioprine in a Patient with Crohn’s Disease

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet · 2002 · 4.2K citations

Veterinary Medicine, Immunology, Pharmacotherapy +12

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

Paul Rutgeerts, William J. Sandborn, Brian G. Feagan et al. · New England Journal of Medicine · 2005 · 3.9K citations · Full text

Pharmacy, Immunology, Pharmacotherapy +14

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

Stephan R. Targan, Stephen B. Hanauer, Sander J. H. van Deventer et al. · New England Journal of Medicine · 1997 · 3.2K citations · Full text

Pharmacy, Immunology, Inflammation +12

The safety profile of infliximab in patients with Crohn’s disease: The Mayo Clinic experience in 500 patients

Jean‐Frédéric Colombel, Edward V. Loftus, William J. Tremaine et al. · Gastroenterology · 2003 · 908 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +13

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

David Knight, Han Trinh, Junming Le et al. · Molecular Immunology · 1993 · 710 citations

Pharmacy, Immunology, Molecular Biology +14